Navigation Links
Saint Luke's Mid America Heart Institute Clinical Trial To Investigate Effectiveness Of Cardiac Surgery Device
Date:2/25/2013

KANSAS CITY, Mo., Feb. 25, 2013 /PRNewswire-USNewswire/ -- Patients undergoing open heart procedures such as coronary artery bypass or valve surgery may be eligible to enroll in a clinical trial available in the Kansas City area only at Saint Luke's Mid America Heart Institute.

The SternaLock® Blu clinical trial will compare patients whose sternum (breastbone) is closed with conventional stainless steel wire to patients whose sternum is closed with Biomet's SternaLock® Blu Primary Closure System to evaluate sternal bone healing following a full median sternotomy.

A median sternotomy is the incision typically used when performing an open heart procedure.  Following the procedure the breast plate is typically put back together with wires. The SternaLock closure uses plates and screws commonly used during orthopedic cases.  This study is designed to determine if one method of sternal closure results in better healing of the breastbone compared to the other and if there are differences in the amount of pain, the use of pain medication, and functional recovery following heart surgery between the two closure methods. More than 700,000 sternotomies are performed in the U.S. annually.

Outcomes in this trial will include bone healing, post-operative pain, analgesic usage, patient function, and quality of life, in addition to economic costs between wires and the SternaLock system.  

Keith Allen , M.D., director of surgical research and a cardiothoracic surgeon at Saint Luke's Mid America Heart Institute, is the trial's national principal investigator. The trial plans to enroll 236 patients from up to 12 leading cardiac centers in the U.S.

"The standard of care to date has been use of wires to close and stabilize the breastbone following cardiac surgery," said Dr. Allen. "Previous research has shown improved bone healing and reduced post-operative pain in patients receiving a rigid fixation device following sternotomy. Saint Luke's looks forward to contributing to the pioneering research into this new surgical option."

Saint Luke's enrolled its first patient on Feb. 8 with a patient who received an aortic valve replacement performed by J. Russell Davis , M.D. The 56-year-old man is healing well after surgery to correct a defective heart valve. 

About Biomet
Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. For more information visit www.biomet.com

About Saint Luke's Mid America Heart Institute
Saint Luke's Mid America Heart Institute, a member of Saint Luke's Health System and a teaching affiliate of the University of Missouri-Kansas City, is one of the preeminent cardiovascular programs in the country. Its legacy of innovation began more than 25 years ago when it opened as the nation's first heart hospital. Since then, the Heart Institute has earned a world-wide reputation for excellence in the treatment of heart disease, including interventional cardiology, cardiovascular surgery, imaging, heart failure, transplant, heart disease prevention, women's heart disease, electrophysiology, outcomes research, and health economics. With more than 50 full-time board certified cardiovascular specialists on staff, the Heart Institute offers one of the largest heart failure/heart transplant programs in the country, has the largest experience with transcatheter aortic valve replacement in the Midwest, and is a global teaching site for the newest approaches to opening challenging blocked arteries using minimally invasive techniques.


'/>"/>
SOURCE Saint Luke's Mid America Heart Institute
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Saint Vincent Health System Selects onFocus Healthcare for Enterprise Performance Management
2. Saint-Gobain Performance Plastics acquires Twin Bay Medical
3. American Academy of Family Physicians Foundation Launches Cities for Life
4. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
5. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
6. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
7. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
8. Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings
9. Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
10. Okuma America Chooses The Daniel Group To Provide Customer Service Research
11. Hill-Rom to Participate in the Bank of America Merrill Lynch 2012 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017 According to a ... (X-ray Imaging Digital, Analog), MRI (Closed, Open), Ultrasound, CT, ... Oncology), End User (Hospitals, Imaging Centers) - Global Forecast ... global market over the forecast period of 2016 to ... Billion by 2021, at a CAGR of 6.6% from ...
(Date:2/23/2017)... , February 23, 2017 The ... the United States . According to the ... cannabis industry is expected to create 283,422 jobs by 2020, ... compounded over the next four years. The accelerating pace of ... the growth of legal cannabis market, which will further create ...
(Date:2/23/2017)...  MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative ... to develop and market advanced products and therapies for ... and Dental sectors of healthcare, today announced its record ... December 31, 2016. Full Year 2016 Highlights ... increase over full year 2015 revenue ...
Breaking Medicine Technology:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Phoenix, announced today that it will soon begin franchising throughout the U.S. starting ... mission to help bring the practice of meditation mainstream. Current Meditation will be ...
(Date:2/23/2017)... , ... ... the perfect opportunity for the nation to come together to ... basketball bracket – with its favorite fruit – apples! To ... apple lovers to join the “Apple Madness” bracket tournament – ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today ... efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling at three ... enrolling children across the United States. , “There are currently no approved drugs ...
(Date:2/23/2017)... ... 2017 , ... Carlos Gutierrez has lived his spiritual life hardly ... which is the purpose of everyone in this universe. As Gutierrez sees the need ... Press) attempts to guide readers to expand one’s spiritual life. , “Our Spiritual Truths” ...
(Date:2/22/2017)... ... ... Gevir, a New Zealand-based company that focuses on developing powder and capsule ... Amazon.com, the world’s largest online retailer. , The company was founded in ... treatment for Shelley’s Multiple Sclerosis, which she’d been diagnosed with at 28 years old. ...
Breaking Medicine News(10 mins):